Induction of Sustained Hypercholesterolemia by Single Adeno-Associated Virus–Mediated Gene Transfer of Mutant hPCSK9
Author(s) -
Marta Roche-Molina,
David SanzRosa,
Francisco M. Cruz,
Jaime GarcíaPrieto,
Sergio López,
Rocı́o Abia,
Francisco J.G. Muriana,
Valentı́n Fuster,
Borja Ibáñez,
Juan A. Bernal
Publication year - 2014
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.114.303617
Subject(s) - adeno associated virus , mutant , gene transfer , familial hypercholesterolemia , gene , genetic enhancement , biology , virology , virus , medicine , genetics , endocrinology , cholesterol , vector (molecular biology) , recombinant dna
Patients with mutations in the proprotein convertase subtilisin/kexin type 9 (PCSK9) gene have hypercholesterolemia and are at high risk of adverse cardiovascular events. We aimed to stably express the pathological human D374Y gain-of-function mutant form of PCSK9 (PCSK9(DY)) in adult wild-type mice to generate a hyperlipidemic and proatherogenic animal model, achieved with a single systemic injection with adeno-associated virus (AAV).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom